Lumax VDD

Quote


















Anonymous said:
What is your idea of 'very very soon'?

Your DF-4 lead is not even close to clinicals yet.
Neither is the MRI ICD.
Your MRI pacemaker is ramping up for clinical evaluation. I hear and see that it is looking to be a nice device but you might see that device in your bag in 2014.

The VDD ICD does seem to be a nice product but outside of picking up some extra business and maybe 2-3 market share points why is 2013 such a big year?
Click to expand...

I met a former Medtronic rep at our sales meeting. They had put in 26 years with mother Med before getting laid off. Also mentioned was that MDT would be laying off another 600 this year sometime.

Meanwhile, Biotronik showed a graph that actually shows that our company has been GROWING over the last 5 years while our competitors have been shrinking.

The DX is a nice conversation piece. It is new technology in a market where NEW isn't too often these days. And early indications are that once a physician implants one, he will like it. I've witnessed 7 so far. 4 were implants I would have gotten regardless. 3 were implants from physicians I haven't worked with ever. Not to mention 2 new BiV's and 2 gen changes from (again) physician that I previously haven't worked with.

The competition is stiff. Our share is still only about 7%. But, in my area, I know that I've picked up a bit of share in the last two weeks.
 






Anonymous said:
I met a former Medtronic rep at our sales meeting. They had put in 26 years with mother Med before getting laid off. Also mentioned was that MDT would be laying off another 600 this year sometime.

Meanwhile, Biotronik showed a graph that actually shows that our company has been GROWING over the last 5 years while our competitors have been shrinking.

The DX is a nice conversation piece. It is new technology in a market where NEW isn't too often these days. And early indications are that once a physician implants one, he will like it. I've witnessed 7 so far. 4 were implants I would have gotten regardless. 3 were implants from physicians I haven't worked with ever. Not to mention 2 new BiV's and 2 gen changes from (again) physician that I previously haven't worked with.

The competition is stiff. Our share is still only about 7%. But, in my area, I know that I've picked up a bit of share in the last two weeks.
Click to expand...

You measure your growth in 2 wk increments? I would love to hear more about the 5 yr graph you referenced. Can you be more specific? Brady vs. tachy vs. competitors.. is it U.S. data?
 






Anonymous said:
You measure your growth in 2 wk increments? I would love to hear more about the 5 yr graph you referenced. Can you be more specific? Brady vs. tachy vs. competitors.. is it U.S. data?
Click to expand...


come on mr idiot wise guy. of course nobody is measuring growth based on 2 weeks. lol, that's hilarious. go back to work. enjoy your marketshare. i will enjoy my small wins and you keep big 3 afloat so that my kid will have a place to train at in a few years when this business is upside down with turbulence. lol.
 






Anonymous said:
come on mr idiot wise guy. of course nobody is measuring growth based on 2 weeks. lol, that's hilarious. go back to work. enjoy your marketshare. i will enjoy my small wins and you keep big 3 afloat so that my kid will have a place to train at in a few years when this business is upside down with turbulence. lol.
Click to expand...

Right your kid will need to train at the big 3 because Bio's training department is only set up for old competitive hires.
 






Anonymous said:
come on mr idiot wise guy. of course nobody is measuring growth based on 2 weeks. lol, that's hilarious. go back to work. enjoy your marketshare. i will enjoy my small wins and you keep big 3 afloat so that my kid will have a place to train at in a few years when this business is upside down with turbulence. lol.
Click to expand...

So where's the data on the graph you saw comparing BIO to the Big 3? Show me some real info and stop getting hung up dishing out sarcasm.
 






Private company has no need to share just because you want to see it. I'm sure a lot of people would love to know how much business Bio is really doing. The truth is, even if it isn't in your area (yet) Bio is growing by double digit percentages year after year, and will continue to do so year after year, and things like the VDD lead are only going to help speed that process up.

And I've seen the graph in question. Bio's growth in the US is almost exponential at this point regarding revenue.
 






Anonymous said:
Private company has no need to share just because you want to see it. I'm sure a lot of people would love to know how much business Bio is really doing. The truth is, even if it isn't in your area (yet) Bio is growing by double digit percentages year after year, and will continue to do so year after year, and things like the VDD lead are only going to help speed that process up.

And I've seen the graph in question. Bio's growth in the US is almost exponential at this point regarding revenue.
Click to expand...

You're a moron...shut up! The reason why BIO doesn't post #'s is because they would have to be made up to look impressive and you know no one would believe it anyway. VDD lead???? Please stop. Why didn't this lead sell in 2006? Where has it been since? Externalized conductors? Where's the data on this lead? You idiots are your biggest enemies. Too busy convincing yourselves that 2004 technology is new. You guys are the scum of scum in our industry and that's just something you have to live with. Good luck with that VDD shit!
 






Anonymous said:
And still Biotronik grows......what a cool company to work for.
Click to expand...

BIO is definitely not growing in their home market with their 20% MS, despite a very strong sales team.
I know this because I work in the CRDM market in Germany. Like other CRDM manufacturers, BIO Germany has just announced headcount reductions and FF restructuring.
The prices for the industry throughout EU are under severe pressure due to DRGs, GPO pressures and government austerity measures. The US continues to "print money" as a temporary fix to avoid what inevitably must hit the fan once the Baby Boomers enter the play. So Helicopter Ben must soon land and refuel.
View this EU show in medical device as that which is coming to a theater near you.
 






Anonymous said:
I met a former Medtronic rep at our sales meeting. They had put in 26 years with mother Med before getting laid off. Also mentioned was that MDT would be laying off another 600 this year sometime.

Meanwhile, Biotronik showed a graph that actually shows that our company has been GROWING over the last 5 years while our competitors have been shrinking.

The DX is a nice conversation piece. It is new technology in a market where NEW isn't too often these days. And early indications are that once a physician implants one, he will like it. I've witnessed 7 so far. 4 were implants I would have gotten regardless. 3 were implants from physicians I haven't worked with ever. Not to mention 2 new BiV's and 2 gen changes from (again) physician that I previously haven't worked with.

The competition is stiff. Our share is still only about 7%. But, in my area, I know that I've picked up a bit of share in the last two weeks.
Click to expand...


True - Biotronik has been growing. Faster than the other 3. But it is because it had negligent market share. Growing from 1 to 2% market share is 100% growth for instance. Biotronik strategy is very different - safer but also without expectations that it can be a serious player. For Biotronik, having 10% of the market share will be the goal. Even if it comes after many years. They are too small to have the issue like Riata, Fidelis. It will burry them. They are not on the stock market to need 10% growth every quarter so that they can please the board and the stock holders. But, on the other hand, they will never be number 1 or 2 or 3 for the exact issues mentioned above.
 






Anonymous said:
True - Biotronik has been growing. Faster than the other 3. But it is because it had negligent market share. Growing from 1 to 2% market share is 100% growth for instance. Biotronik strategy is very different - safer but also without expectations that it can be a serious player. For Biotronik, having 10% of the market share will be the goal. Even if it comes after many years. They are too small to have the issue like Riata, Fidelis. It will burry them. They are not on the stock market to need 10% growth every quarter so that they can please the board and the stock holders. But, on the other hand, they will never be number 1 or 2 or 3 for the exact issues mentioned above.
Click to expand...

How would you like to work for a company that is 1 recall away from being out of business and expected to engage in shady sales tactics just to get a doc to try your shit. On top of all that, to know you work for a company that if you get layed off you don't have enough business to bring to any company and you're done! Just to add fuel to the fire, having BIO on your resume as your last employer is a death sentence for future prospects. Based on all these shortcomings I understand why you operate like scumbags...it's because you have to.
 






Anonymous said:
How would you like to work for a company that is 1 recall away from being out of business and expected to engage in shady sales tactics just to get a doc to try your shit. On top of all that, to know you work for a company that if you get layed off you don't have enough business to bring to any company and you're done! Just to add fuel to the fire, having BIO on your resume as your last employer is a death sentence for future prospects. Based on all these shortcomings I understand why you operate like scumbags...it's because you have to.
Click to expand...

amazing how short sighted many of you are on this board. 10% of the CRM market is a huge step for a company such as Biotronik. huge. whY? the big 3 are well entrenched and revenues and asps are shrinking. nobody even wants to get into this market (not abbott, not JNJ, not anyone rumored over the last decade or so).

reps having bio on their resume will be fine if they leave. why? if they can show marketshare in this industry that is greater than the national avearage of 7% then they are an overachiever. the problem is that bio reps the work in relevant volume will not go anywhere because they are making a decent living and enjoy beating the odds.

time will tell.
 






I am selling this as fast as I can get my hands on it. I only did 12 ICD's all of last year (mostly trail devices), I have now put 14 Lumax DX in since launch, 3 last week with EP's who have never used my ICD's before and they loved it. I am sure i'm not the only person having success like this nationally. This thing is changing the landscape for us.
 






Anonymous said:
....holy cow! Whatever you're smoking...can I have some? It seems to be awesome!
Click to expand...

BIO sells their top-end DR-IPGs ( Evia, Entovis) in their home market for around 900 Euros ( 1200 US $). Add about 600 US $ for home monitoring. Total price is $1800 in Germany. They are selling them for this price, so they must at least be breaking even ......

Just to let you girl scouts know what the lower end of pricing really looks like.

a friendly update from the Fatherland ....
 






Dumas - ever seen sweater shock on reveal?
Stj made reveal for MDT (thru ANSacquisition)
Until contract ran out. Then stj Ilr was better.
Now biot may have the next mousetrap - big whoop
It's an ilr....

QUOTE=Anonymous;4664692]The Loop recorder seems an interesting device. Could you help me out with some more info:

- Is it MRI conditional?
- Cleaner EGMs? Cleaner than what? What is the proof you could share to back up your claims?
- Wasn't the pacemaker location exactly the spot where you capture the biggest myopotential signals?
- Wasn't there an elevated infection risk when you re-use an implant pocket?
- Could you share some evidence about sensitivity and efficacy? I'm sure you do have clinical studies to provide evidence your ILR works?
- I'd be especially interested in AF detection. Do you have some evidence to proof the ILRs AF detection capabilities?
- How do you trigger recordings? I'd like to understand how symptom correlation is assured

Thanks allot in advance for your help.[/QUOTE]
 






Top Bottom
Back
Quote